Status:
ACTIVE_NOT_RECRUITING
Parenting Intervention for Mothers With Substance Use Disorder
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
Washington University School of Medicine
Conditions:
Substance Use Disorders
Children of Mothers With Substance Use Disorders
Eligibility:
All Genders
3+ years
Phase:
NA
Brief Summary
Children of mothers with substance use disorder (SUD) constitute a growing and highly vulnerable population. Evidence-based parenting interventions have the potential to both support parents' recovery...
Eligibility Criteria
Inclusion
- Mothers:
- English speaking
- ≥ 18 years of age
- Mother to an index child between 3 years, 0 months to 6 years, 11 months of age who receives primary care at Boston Medical Center
- Primary caregiver to the index child,
- Engaged in formal SUD recovery supports (e.g., medication for opioid use disorder, support groups specific to people in recovery and falls into one of these two enrollment groups: A) "high-risk" substance use disorder defined \>=1 episode of relapse within the past two years OR B) "low-risk" defined as zero episodes of relapse within the past two years.
- Children:
- Between 3 years, 0 months to 6 years, 11 months of age,
- Enrolled mother is primary caregiver.
- THRIVE Therapist:
- Embedded social worker in the SOFAR program delivering the THRIVE intervention
- Clinical Stakeholders:
- Patient Navigators, program manager, pediatricians, peer recovery coaches involved in the care of mother-child dyads in the SOFAR Program.
Exclusion
- Mothers:
- Has an index child who has complex medical problems (e.g., autism spectrum disorder) that significantly impact the child's ability to interact with the parent (determination by child's primary care pediatrician)
- Severe cognitive limitation or medical or psychiatric condition that limits their capacity to provide informed consent
- Concurrent participation in another parent training intervention
- Children:
- Has any complex medical problems (as assessed by their pediatrician) that significantly impact the child's ability to interact with the mother.
Key Trial Info
Start Date :
January 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2026
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT06489522
Start Date
January 17 2025
End Date
March 1 2026
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center, SOFAR Clinic
Boston, Massachusetts, United States, 02118